The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3-and 6-month response rates in trials of biological agents

M. Boers

doi:https://doi.org/10.1136/ard.2009.115832

The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3-and 6-month response rates in trials of biological agents

M. Boers

Epidemiology and Data Science (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	186-192
Journal	Annals of the rheumatic diseases
Volume	69
Issue number	1
DOIs	https://doi.org/10.1136/ard.2009.115832
Publication status	Published - 2010

Access to Document

https://doi.org/10.1136/ard.2009.115832

Cite this

@article{dcc57cc41d0c4df9bdf8fb0b8852284d,

title = "The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3-and 6-month response rates in trials of biological agents",

author = "M. Boers",

year = "2010",

doi = "https://doi.org/10.1136/ard.2009.115832",

language = "Undefined/Unknown",

volume = "69",

pages = "186--192",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3-and 6-month response rates in trials of biological agents

AU - Boers, M.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.1136/ard.2009.115832

DO - https://doi.org/10.1136/ard.2009.115832

M3 - Article

C2 - 19773287

SN - 0003-4967

VL - 69

SP - 186

EP - 192

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 1

ER -